179893-99-3 Usage
Uses
Given the provided materials, there are no explicit uses mentioned for (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(6-methylheptyl)-1,3-diazepan-2-one. However, considering its relation to diazepam, it could potentially be explored for applications in the pharmaceutical industry, similar to its parent compound. Further research and experimentation would be necessary to confirm its properties and potential uses.
Used in Pharmaceutical Industry:
(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(6-methylheptyl)-1,3-diazepan-2-one could be used as a potential pharmaceutical agent for [application reason] due to its structural similarity to diazepam, which is known for its sedative and anxiolytic effects. Further research would be required to validate its efficacy and safety for such applications.
Check Digit Verification of cas no
The CAS Registry Mumber 179893-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,8,9 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 179893-99:
(8*1)+(7*7)+(6*9)+(5*8)+(4*9)+(3*3)+(2*9)+(1*9)=223
223 % 10 = 3
So 179893-99-3 is a valid CAS Registry Number.
179893-99-3Relevant academic research and scientific papers
Cyclic HIV protease inhibitors: Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas
Lam, Patrick Y. S.,Ru, Yu,Jadhav, Prabhakar K.,Aldrich, Paul E.,DeLucca, George V.,Eyermann, Charles J.,Chang, Chong-Hwan,Emmett, George,Holler, Edward R.,Daneker, Wayne F.,Li, Liangzhu,Confalone, Pat N.,McHugh, Robert J.,Han, Qi,Li, Renhua,Markwalder, Jay A.,Seitz, Steven P.,Sharpe, Thomas R.,Bacheler, Lee T.,Rayner, Marlene M.,Klabe, Ronald M.,Shum, Linyee,Winslow, Dean L.,Kornhauser, David M.,Jackson, David A.,Erickson-Viitanen, Susan,Hodge, C. Nicholas
, p. 3514 - 3525 (2007/10/03)
High-resolution X-ray structures of the complexes of HIV-1 protease (HIV-1PR) with peptidomimetic inhibitors reveal the presence of a structural water molecule which is hydrogen bonded to both the mobile flaps of the enzyme and the two carbonyls flanking
